Total amount raised
$80M
Latest funding date
2025-04-03
Location
Lindus Health has successfully raised funding across six rounds, with the latest being a grant, supported by 22 investors including ARIA and Seedcamp. The company is recognized for its innovative approach to clinical trials, branding itself as the "Anti-CRO" for life sciences.
What Is Lindus Health?
Lindus Health, founded in 2021, is a pioneering Contract Research Organization (CRO) based in London, England. The company specializes in conducting end-to-end clinical trials for the life sciences sector, branding itself as the \"Anti-CRO\"for its innovative approach.
Operating in industries such as Biotechnology, Clinical Trials, Health Care, and Medical, Lindus Health employs between 101-250 people. The company leverages in-house technology to streamline clinical trials, ensuring faster and more reliable outcomes.
How Much Funding Has Lindus Health Raised?
- Seed Round
- Amount Raised: USD 5,000,000
- Date: November 2021
- Lead Investors: Firstminute Capital, Presight Capital, Seedcamp
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale the team and build Lindus Health's full-stack clinical trial platform.
- Grant
- Amount Raised: GBP 436,603
- Date: May 2023
- Lead Investors: Innovate UK
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To fund specific research and development projects.
- Angel Round
- Amount Raised: USD 1,000,000
- Date: June 2023
- Lead Investors: Peter Thiel
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support early-stage growth and initial market expansion.
- Series A
- Amount Raised: USD 18,000,000
- Date: August 2023
- Lead Investors: Creandum
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To further develop Lindus Health's clinical trial platform and expand its operations.
- Series B
- Amount Raised: USD 55,000,000
- Date: January 2025
- Lead Investors: Balderton Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To further develop Lindus Health's AI technology and eClinical platform, Citrus™, and to hire in key areas such as clinical operations and product development.
- Grant
- Amount Raised: Not publicly disclosed
- Date: April 2025
- Lead Investors: ARIA (Advanced Research and Invention Agency)
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To fund development of safe and reliable AI for clinical trial design as part of ARIA's Safeguarded AI programme.
Total Amount Raised: At least USD 79,436,603 based on disclosed funding (ARIA grant amount undisclosed).
Current Valuation: Not publicly disclosed
Key Investors
- Balderton Capital
- Details: Balderton Capital is a leading European venture capital firm with over two decades of experience. They focus on investing in technology companies at early and growth stages.
- Investment Focus Areas: AI, fintech, B2B SaaS, digital health, mobility, gaming, marketplace companies.
- Notable Investments: Revolut, Citymapper, The Hut Group.
- Creandum
- Details: Creandum is a European venture capital firm that invests in early-stage technology companies. They have a strong track record of supporting innovative startups.
- Investment Focus Areas: Early-stage technology companies.
- Notable Investments: Spotify, Klarna, iZettle.
- Firstminute Capital
- Details: Firstminute Capital is a London-based seed fund that backs early-stage technology startups. They are known for their global network of founders and investors.
- Investment Focus Areas: Early-stage technology companies.
- Notable Investments: CloudNC, Pangaea, Automata.
- Seedcamp
- Details: Seedcamp is a European seed fund that invests in early-stage startups across various sectors. They have a reputation for identifying and nurturing high-potential companies.
- Investment Focus Areas: Early-stage startups across various sectors.
- Notable Investments: TransferWise, Revolut, UiPath.
- Peter Thiel
- Details: Peter Thiel is a billionaire entrepreneur and venture capitalist known for his early investments in groundbreaking technology companies. He co-founded PayPal and Palantir Technologies.
- Investment Focus Areas: Technology and innovation.
- Notable Investments: Facebook, Palantir Technologies, SpaceX.
- Visionaries Club
- Details: Visionaries Club is a European venture capital firm that participated in the Series B round as a new investor alongside Balderton Capital.
- Investment Focus Areas: Technology and digital health.
- Notable Investments: Various European technology startups.
What's Next for Lindus Health?
Lindus Health stands at the cusp of a transformative era in clinical trials, leveraging AI and big data through their Citrus™ platform. The company is poised to disrupt the $112 billion CRO industry by offering faster, more reliable, and cost-effective trials. With a track record of enrolling over 36,000 patients and running 42 end-to-end trials, the potential for growth is immense.
Future fundraising opportunities are promising, with the recent $55 million Series B round setting the stage for additional venture capital rounds or strategic partnerships. As Lindus Health continues to demonstrate its value, an IPO could also be on the horizon. However, challenges such as regulatory hurdles, competition from traditional CROs, and ensuring data security will need to be navigated carefully.
Use Clay to Get Funding Data
Sales professionals, take your strategy to the next level by leveraging Clay's platform to access comprehensive fundraising data on companies like Lindus Health and gather other critical business insights. Sign up for free and unlock the potential of data-driven decision-making today.
